This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mann, D. L. Articles by Taegtmeyer, H. Search for Related Content PubMed PubMed Citation Articles by Mann, D. L. Articles by Taegtmeyer, H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Heart Failure

(Circulation. 2001;104:1089.)
© 2001 American Heart Association, Inc.

Editorials

Dynamic Regulation of the Extracellular Matrix After Mechanical Unloading of the Failing Human Heart

Recovering the Missing Link in Left Ventricular Remodeling

Douglas L. Mann, MD; Heinrich Taegtmeyer, MD

From the Winters Center for Heart Failure Research, Cardiology Section, Department of Medicine, Veterans Administration Medical Center and Baylor College of Medicine (D.L.M.), and the Division of Cardiology, Department of Medicine, University of Texas Health Science Center (H.T.), Houston, Tex.

Correspondence and reprint requests to Douglas L. Mann, MD, Cardiology Research (151C), VA Medical Center, 2002 Holcombe Blvd, Houston, TX 77030. E-mail dmann@bcm.tmc.edu

Key Words: Editorials • heart diseases • remodeling • heart failure • surgery

One of the most exciting scientific challenges that faces investigators in the field of heart failure today is to unravel the mechanisms that are responsible for preventing and/or reversing the process of left ventricular (LV) remodeling (dilation) in the failing heart. Given that LV remodeling may contribute to disease progression in heart failure¹ and that all drugs that have been shown to exert beneficial effects on mortality in patients with heart failure also favorably impact the remodeling process,^2–4 it is likely that the quest to identify the mechanisms responsible for reversing LV remodeling will lead to the identification of novel therapeutic targets for the treatment of heart failure. Thus far, clinical studies with ß-blockers and left ventricular assist devices (LVADs) have consistently shown that these 2 treatment modalities allow the heart to become smaller and to assume a more normal prolate ellipsoid geometry,^2,5 thus increasing the mechanical efficiency of the heart.² However, it is not at all intuitively obvious how or why this occurs. Moreover, although considerable research time and effort has (justifiably) been expended on understanding the basic mechanisms that promote LV dilation, it is not clear that a simple reversal of these same mechanisms will allow the heart to revert back to its normal size and shape. Thus, our understanding of the mechanisms that are responsible for the regression of LV remodeling remains far from complete.

See p 1147

The clinical experience with LVADs has yielded a number of unique insights into the mechanisms of the LV remodeling, . . . [Full Text of this Article]

This article has been cited by other articles:

				G. K. R. Soppa, R. T. Smolenski, N. Latif, A. H. Y. Yuen, A. Malik, J. Karbowska, Z. Kochan, C. M. N. Terracciano, and M. H. Yacoub Effects of chronic administration of clenbuterol on function and metabolism of adult rat cardiac muscle Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1468 - H1476. [Abstract] [Full Text] [PDF]

				S. Y. Boateng, S. S. Lateef, W. Mosley, T. J. Hartman, L. Hanley, and B. Russell RGD and YIGSR synthetic peptides facilitate cellular adhesion identical to that of laminin and fibronectin but alter the physiology of neonatal cardiac myocytes Am J Physiol Cell Physiol, January 1, 2005; 288(1): C30 - C38. [Abstract] [Full Text] [PDF]

				T Hayashi, K Sohmiya, A Ukimura, S Endoh, T Mori, H Shimomura, M Okabe, F Terasaki, and Y Kitaura Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart Heart, October 1, 2003; 89(10): 1236 - 1242. [Abstract] [Full Text] [PDF]

				B. S. McGowan, C. B. Scott, A. Mu, R. J. McCormick, D. P. Thomas, and K. B. Margulies Unloading-induced remodeling in the normal and hypertrophic left ventricle Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2061 - H2068. [Abstract] [Full Text] [PDF]

				B. A. J. M. de Mol Mechanical Support in Acute Perioperative Heart Failure: Are Assist Devices Smart Enough to Heal the Heart? Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2003; 7(1): 105 - 109. [PDF]

				P. W. M. Fedak, S. M. Altamentova, R. D. Weisel, N. Nili, N. Ohno, S. Verma, T.-Y. J. Lee, C. Kiani, D. A. G. Mickle, B. H. Strauss, et al. Matrix remodeling in experimental and human heart failure: a possible regulatory role for TIMP-3 Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H626 - H634. [Abstract] [Full Text] [PDF]

				A.B. Taegtmeyer and P.J.R. Barton SNP at your own risk Eur. Heart J., May 1, 2002; 23(9): 692 - 694. [Full Text] [PDF]

				Y. Y. Li, T. Kadokami, P. Wang, C. F. McTiernan, and A. M. Feldman MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H983 - H989. [Abstract] [Full Text] [PDF]